Fuula Jalqabaa › Tajaajiltoota › ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc.: Baajannaa H-1B fi deggera
ReCode Therapeutics, Inc. iyyannoo hojii haala 10 H-1B fi viizaa walitti dhufeenya qaban bara maallaqaa 2023–2026 irratti galche; mirkaneessame: 10. Baajannaa giddugaleessaa dhiyaate: $113,629.
ReCode Therapeutics, Inc. viizaa H-1B deggeraa?
ReCode Therapeutics, Inc. bara maallaqaa 2023–2026 irratti iyyannoo hojii haala 10 galche, kan haaraan 14-Elb-2025 irratti dhiyaate. LCA tarsiimoo jalqabaa iyyannoo H-1B ti, hojii kennaan hojjettoota H-1B deggereera yookaan deggeruuf qophii ta'eera; hojii adda addaaf deggera hin mirkaneessu. Galmee hojii hojii kennaa isaa ilaali.
Baajannaa maqaa hojii irratti
| Mata-duree hojii | LCAs | Baasii giddu-galeessaa |
|---|---|---|
| Scientist II | 2 | $135,000 |
| Senior Research Associate I, Gene Editing | 1 | $115,000 |
| Research Associate, Aerosol - Lipid Nano Particle | 1 | $79,560 |
| Senior Manager, IT Infrastructure and Security | 1 | $185,000 |
| Research Associate II | 1 | $90,000 |
| Senior Director, Formulations and Process Development | 1 | $148,408 |
| Research Associate II, Bioanalytical | 1 | $88,000 |
| Scientist I, In Vitro Pharmacology | 1 | $112,258 |
| Senior Research Associate I | 1 | $76,000 |
Iyyannoo bara maallaqaa irratti
| Bara maallaqaa | LCAs | Baasii giddu-galeessaa |
|---|---|---|
| FY2023 | 4 | $110,000 |
| FY2024 | 3 | $115,000 |
| FY2025 | 3 | $112,258 |
Sadarkaa baajannaa olaanaa
- Sadarkaa I (jalqabsiisa)10%
- Sadarkaa II (qajeelaa)30%
- Sadarkaa III (muuxannoo qabu)20%
- Sadarkaa IV (gahumsa guutuu)40%
Dhaabbanni Hojii sadarkaa baajannaa olaanaa afur hojii tokkoo tokkoo fi bakkaaf, Sadarkaa I (jalqabaa) hanga Sadarkaa IV (guddisaa) jiru, kaa'a. Hojii kennaan sadarkaa hojii sanaaf madaalu filata.
Hojiiwwan eessa jiru
Hojiiwwan
- Molecular and Cellular Biologists5
- Bioengineers and Biomedical Engineers2
- Biological Technicians2
- Computer and Information Systems Managers1
Iyyannoo haaraa
| Mata-duree hojii | Baasii bu'uuraa | Bakka | Dhiyaate | Guyyaa jalqabaa | Haala |
|---|---|---|---|---|---|
| Scientist I, In Vitro Pharmacology | $112,258–$130,000 Sadarkaa II | Menlo Park, CA | 14-Elb-2025 | 01-Onk-2025 | Mirkaneffame |
| Senior Director, Formulations and Process Development | $148,408–$275,000 Sadarkaa IV | Menlo Park, CA | 04-Wax-2024 | 01-Onk-2024 | Mirkaneffame |
| Research Associate II, Bioanalytical | $88,000 Sadarkaa IV | Menlo Park, CA | 03-Cam-2024 | 01-Onk-2024 | Mirkaneffame |
| Scientist II | $130,000 Sadarkaa III | Menlo Park, CA | 04-Hag-2023 | 01-Onk-2023 | Mirkaneffame |
| Research Associate II | $90,000 Sadarkaa IV | Menlo Park, CA | 11-Ado-2023 | 31-Ado-2023 | Mirkaneffame |
| Research Associate, Aerosol - Lipid Nano Particle | $79,560 Sadarkaa I | Menlo Park, CA | 03-Cam-2023 | 01-Onk-2023 | Mirkaneffame |
| Senior Manager, IT Infrastructure and Security | $185,000 Sadarkaa II | Menlo Park, CA | 21-Elb-2023 | 15-Cam-2023 | Mirkaneffame |
| Scientist II | $140,000 Sadarkaa IV | Menlo Park, CA | 17-Elb-2023 | 01-Cam-2023 | Mirkaneffame, erga haqamee |
| Senior Research Associate I, Gene Editing | $115,000 Sadarkaa III | Menlo Park, CA | 01-Bit-2023 | 13-Bit-2023 | Mirkaneffame, erga haqamee |
| Senior Research Associate I | $76,000 Sadarkaa II | Dallas, TX | 24-Cam-2022 | 01-Onk-2022 | Mirkaneffame, erga haqamee |
Baajanni gatii gadii gatii hojii iyyannoo tokkoo tokkoon irratti dhiyaate yoo ta'u, gara baajannaa waggaatti jijjiirame; lakkoofsa hojii guutuu hamma guyyaa guutuu qofa fayyadama. LCA mirkaneessa viizaa miti; LCA tokko hojii hedduu haguuchuuf ni danda'a. Madda: Dhaabbata Hojii Ameerikaa, OFLC LCA Disclosure Data, bara maallaqaa 2023–2026 (murtii haaraa 30-Wax-2026).